LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | PD184352 | 0.37 | uM | LJP5 | 72 | hr | 962 | 3931 | 10512 | 0.3738 | 0.5033 |
MCF 10A | PD184352 | 1.11 | uM | LJP5 | 72 | hr | 962 | 3432 | 10512 | 0.3264 | 0.4450 |
MCF 10A | PD184352 | 3.33 | uM | LJP5 | 72 | hr | 962 | 2663 | 10512 | 0.2533 | 0.3430 |
MCF 10A | PD184352 | 10 | uM | LJP5 | 72 | hr | 962 | 1578 | 10512 | 0.1501 | 0.1533 |
MCF 10A | PLX-4720 | 0.04 | uM | LJP5 | 72 | hr | 962 | 10086 | 10512 | 0.9595 | 0.9760 |
MCF 10A | PLX-4720 | 0.12 | uM | LJP5 | 72 | hr | 962 | 9619 | 10512 | 0.9150 | 0.9489 |
MCF 10A | PLX-4720 | 0.37 | uM | LJP5 | 72 | hr | 962 | 9239 | 10512 | 0.8789 | 0.9264 |
MCF 10A | PLX-4720 | 1.11 | uM | LJP5 | 72 | hr | 962 | 9201 | 10512 | 0.8754 | 0.9242 |
MCF 10A | PLX-4720 | 3.33 | uM | LJP5 | 72 | hr | 962 | 9312 | 10512 | 0.8860 | 0.9309 |
MCF 10A | PLX-4720 | 10 | uM | LJP5 | 72 | hr | 962 | 8942 | 10512 | 0.8511 | 0.9085 |
MCF 10A | Lapatinib | 0.04 | uM | LJP6 | 72 | hr | 962 | 10747 | 10692 | 1.0052 | 1.0030 |
MCF 10A | Lapatinib | 0.12 | uM | LJP6 | 72 | hr | 962 | 10580 | 10692 | 0.9895 | 0.9939 |
MCF 10A | Lapatinib | 0.37 | uM | LJP6 | 72 | hr | 962 | 10615 | 10692 | 0.9929 | 0.9959 |
MCF 10A | Lapatinib | 1.11 | uM | LJP6 | 72 | hr | 962 | 10191 | 10692 | 0.9533 | 0.9726 |
MCF 10A | Lapatinib | 3.33 | uM | LJP6 | 72 | hr | 962 | 8583 | 10692 | 0.8028 | 0.8774 |
MCF 10A | Lapatinib | 10 | uM | LJP6 | 72 | hr | 962 | 2659 | 10692 | 0.2487 | 0.3382 |
MCF 10A | Sirolimus | 0.04 | uM | LJP6 | 72 | hr | 962 | 9348 | 10692 | 0.8743 | 0.9241 |
MCF 10A | Sirolimus | 0.12 | uM | LJP6 | 72 | hr | 962 | 9527 | 10692 | 0.8911 | 0.9347 |
MCF 10A | Sirolimus | 0.37 | uM | LJP6 | 72 | hr | 962 | 9293 | 10692 | 0.8691 | 0.9207 |
MCF 10A | Sirolimus | 1.11 | uM | LJP6 | 72 | hr | 962 | 9424 | 10692 | 0.8814 | 0.9286 |
MCF 10A | Sirolimus | 3.33 | uM | LJP6 | 72 | hr | 962 | 9200 | 10692 | 0.8605 | 0.9152 |
MCF 10A | Sirolimus | 10 | uM | LJP6 | 72 | hr | 962 | 9031 | 10692 | 0.8446 | 0.9049 |
MCF 10A | ZSTK474 | 0.04 | uM | LJP6 | 72 | hr | 962 | 10688 | 10692 | 0.9996 | 0.9996 |
MCF 10A | ZSTK474 | 0.12 | uM | LJP6 | 72 | hr | 962 | 9117 | 10692 | 0.8526 | 0.9099 |
MCF 10A | ZSTK474 | 0.37 | uM | LJP6 | 72 | hr | 962 | 7328 | 10692 | 0.6853 | 0.7934 |